Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 25

Trial Status

Completed3
Recruiting1
Terminated1

Role Distribution

Principal Investigator4
Other Roles1
PI Rate80%

Activity Timeline

Clinical Trials (5)

NCT06345495Phase 2Recruiting
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
MyelofibrosisSplenomegaly
PrincipalinvestigatorStart date: 2024-10-01
NCT02410551Phase 2Terminated
Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)
Myeloproliferative Diseases
PrincipalinvestigatorStart date: 2015-06-15
NCT01572662Phase 2Completed
Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
PrincipalinvestigatorStart date: 2012-04-11
NCT01000051Phase 2Completed
Eltrombopag for Post Transplant Thrombocytopenia
Thrombocytopenia
StudychairStart date: 2010-02-17
NCT00475020Phase 2Completed
Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome
Myelofibrosis
PrincipalinvestigatorStart date: 2006-01-04

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

Multiple MyelomaLeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive+6 more
Similarity Score21%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

LeukemiaLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL Positive+4 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNovartis Pharmaceuticals
Similarity Score16%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Multiple MyelomaLeukemia, Myeloid, AcuteHodgkin Disease+4 more
Similarity Score16%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Lymphocytic, Chronic, B-Cell+2 more

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score12%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

Related
18 trials

Shared therapeutic areas:

LeukemiaMyelodysplastic SyndromesLeukemia, Myeloid, Acute+2 more

Worked with same sponsors:

Incyte CorporationM.D. Anderson Cancer Center
Similarity Score12%

Qifa Liu

Nanfang Hospital, Southern Medical University

Related
33 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMyelodysplastic SyndromesPrecursor Cell Lymphoblastic Leukemia-Lymphoma+1 more
Similarity Score9%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, Myeloid, AcuteLeukemia
Similarity Score7%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteMultiple MyelomaMyelodysplastic Syndromes
Similarity Score7%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lymphoma, Non-HodgkinMultiple MyelomaLeukemia, Lymphocytic, Chronic, B-Cell

Worked with same sponsors:

CTI BioPharmaNovartis Pharmaceuticals
Similarity Score7%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

Related
13 trials

Shared therapeutic areas:

LeukemiaHodgkin DiseaseLymphoma, Non-Hodgkin

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score7%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT06345495Phase 2PrincipalInvestigator

High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

MyelofibrosisSplenomegaly
Recruiting
NCT02410551Phase 2PrincipalInvestigator

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

Myeloproliferative Diseases
Terminated
NCT01572662Phase 2PrincipalInvestigator

Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaChronic Lymphocytic Leukemia+7 more
Completed
NCT01000051Phase 2StudyChair

Eltrombopag for Post Transplant Thrombocytopenia

Thrombocytopenia
Completed
NCT00475020Phase 2PrincipalInvestigator

Allogeneic Stem Cell Transplantation for Myelofibrosis and Myelodysplastic Syndrome

Myelofibrosis
Completed

All 5 trials loaded